Company: QTIWW
Filing Date: 2025-08-07
Form Type: DEFA14A
Source: 0001844505-25-000081
Chunk: 5

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-08-07
Form: DEFA14A
Chunk 5
---
 purchase offer, tender offer or exchange offer, Yorkville made no election among different forms of consideration in the purchase offer, tender offer or exchange offer and thereby received the default consideration provided to non-electing stockholders) had Yorkville exercised the Amended Yorkville Warrant in full prior to the consummation of the Acquisition (including if the Acquisition is a purchase offer, tender offer or exchange offer, the expiration thereof), and if the Acquisition is a purchase offer, tender offer or exchange offer, had Yorkville accepted such offer and the same percentage of the Common Stock held by Yorkville as a result of such exercise had been purchased following such acceptance of the purchase offer, tender offer or exchange offer pursuant to such purchase offer, tender offer or exchange offer as the percentage of Common Stock actually purchased pursuant to such purchase offer, tender offer or exchange offer (relative to the number of shares actually tendered in such purchase offer, tender offer or exchange offer). The Amended Yorkville Warrant is exercisable until February 26, 2030 and resulted in equity-classified warrants for accounting purposes.

#### Outlook for the Balance of 2025
The Company reiterates its plans to deliver $18 million in revenue in 2025 (shipment of 40 scanners) and $27 million in revenue in 2026 (shipment of 60 scanners). These targets are in accordance with the committed orders MOQs per its Amended Distribution Agreement with its strategic business and distribution partner, NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA.

*Refer to the “Non-GAAP Financial Measures” section in this press release.

<div align='center'>Page 4</div>

### Summary of Results for the Three and Six Months Ended

#### June 30, 2025 and 2024
<div align='center'>(Unaudited)</div>

| $ thousands (except share and per share amounts)                                |     | 2025 | Three Months Ended June 30, |     | 2024 |            |     | 2025 | Six Months Ended 
         June 30, |     | 2024 |            |
|:--------------------------------------------------------------------------------|:----|:-----|----------------------------:|:----|:-----|-----------:|:----|:-----|-----------------:|:----|:-----|-----------:|
| Revenue                                                                         |     | $    |                       3,659 |     | $    |      1,714 |     | $    |